These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11249507)

  • 1. Replicating herpes simplex virus vectors for cancer gene therapy.
    Yeung SN; Tufaro F
    Expert Opin Pharmacother; 2000 May; 1(4):623-31. PubMed ID: 11249507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic virus therapy using genetically engineered herpes simplex viruses.
    Todo T
    Front Biosci; 2008 Jan; 13():2060-4. PubMed ID: 17981691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene delivery using herpes simplex virus vectors.
    Burton EA; Fink DJ; Glorioso JC
    DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer with herpes simplex vectors.
    Lachmann RH; Efstathiou S
    Curr Opin Mol Ther; 1999 Oct; 1(5):622-32. PubMed ID: 11249669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses.
    Adusumilli PS; Stiles BM; Chan MK; Mullerad M; Eisenberg DP; Ben-Porat L; Huq R; Rusch VW; Fong Y
    J Gene Med; 2006 May; 8(5):603-15. PubMed ID: 16475242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic Herpes Simplex Virus Vectors Fully Retargeted to Tumor- Associated Antigens.
    Uchida H; Hamada H; Nakano K; Kwon H; Tahara H; Cohen JB; Glorioso JC
    Curr Cancer Drug Targets; 2018; 18(2):162-170. PubMed ID: 28176649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of herpes simplex virus-based vectors for gene delivery to the nervous system.
    Lachmann RH; Efstathiou S
    Mol Med Today; 1997 Sep; 3(9):404-11. PubMed ID: 9302691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective replicating viral vectors : potential for use in cancer gene therapy.
    Nemunaitis J
    BioDrugs; 2003; 17(4):251-62. PubMed ID: 12899642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic herpes simplex virus vectors for cancer virotherapy.
    Varghese S; Rabkin SD
    Cancer Gene Ther; 2002 Dec; 9(12):967-78. PubMed ID: 12522436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications.
    Advani SJ; Weichselbaum RR; Whitley RJ; Roizman B
    Clin Microbiol Infect; 2002 Sep; 8(9):551-63. PubMed ID: 12427216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advance in herpes simplex viruses for cancer therapy.
    Liu S; Dai M; You L; Zhao Y
    Sci China Life Sci; 2013 Apr; 56(4):298-305. PubMed ID: 23564184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical application of herpes simplex virus.
    Watanabe D
    J Dermatol Sci; 2010 Feb; 57(2):75-82. PubMed ID: 19939634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant.
    Ikeda K; Wakimoto H; Ichikawa T; Jhung S; Hochberg FH; Louis DN; Chiocca EA
    J Virol; 2000 May; 74(10):4765-75. PubMed ID: 10775615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus vectors for gene therapy.
    Latchman DS
    Mol Biotechnol; 1994 Oct; 2(2):179-95. PubMed ID: 7866875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus-based vectors for the treatment of cancer and neurodegenerative disease.
    Latchman DS
    Curr Opin Mol Ther; 2005 Oct; 7(5):415-8. PubMed ID: 16248276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models.
    Terada K; Wakimoto H; Tyminski E; Chiocca EA; Saeki Y
    Gene Ther; 2006 Apr; 13(8):705-14. PubMed ID: 16421599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication-competent herpes simplex vectors: design and applications.
    Argnani R; Lufino M; Manservigi M; Manservigi R
    Gene Ther; 2005 Oct; 12 Suppl 1():S170-7. PubMed ID: 16231051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus vectors for gene delivery to a variety of different cell types.
    Latchman DS
    Curr Gene Ther; 2002 Dec; 2(4):415-26. PubMed ID: 12477253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSV as a vector in vaccine development and gene therapy.
    Marconi P; Argnani R; Epstein AL; Manservigi R
    Adv Exp Med Biol; 2009; 655():118-44. PubMed ID: 20047039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus-based vectors.
    Lachmann R
    Int J Exp Pathol; 2004 Oct; 85(4):177-90. PubMed ID: 15312123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.